The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses.

MLA

Casillo, Francesco, et al. “The Monoclonal CGRP-Receptor Blocking Antibody Erenumab Has Different Effects on Brainstem and Cortical Sensory-Evoked Responses.” Cephalalgia : An International Journal of Headache, vol. 42, no. 11–12, Oct. 2022, pp. 1236–45. EBSCOhost, https://doi.org/10.1177/03331024221103811.

APA

Casillo, F., Sebastianelli, G., Di Renzo, A., Cioffi, E., Parisi, V., Di Lorenzo, C., Serrao, M., & Coppola, G. (2022). The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses. Cephalalgia : An International Journal of Headache, 42(11–12), 1236–1245. https://doi.org/10.1177/03331024221103811

Chicago

Casillo, Francesco, Gabriele Sebastianelli, Antonio Di Renzo, Ettore Cioffi, Vincenzo Parisi, Cherubino Di Lorenzo, Mariano Serrao, and Gianluca Coppola. 2022. “The Monoclonal CGRP-Receptor Blocking Antibody Erenumab Has Different Effects on Brainstem and Cortical Sensory-Evoked Responses.” Cephalalgia : An International Journal of Headache 42 (11–12): 1236–45. doi:10.1177/03331024221103811.